Minireviews
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2022; 28(26): 3092-3100
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3092
Shared decision-making in the management of patients with inflammatory bowel disease
Kai Song, Dong Wu
Kai Song, Dong Wu, Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China
Author contributions: Song K proposed the article framework and performed the majority of the writing; and Wu D settled down the outline and revised the article
Supported by Peking Union Medical College, No. 2019zlgc0503.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong Wu, MD, Professor, Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. wudong@pumch.cn
Received: January 16, 2022
Peer-review started: January 16, 2022
First decision: April 11, 2022
Revised: April 21, 2022
Accepted: June 19, 2022
Article in press: June 19, 2022
Published online: July 14, 2022
Core Tip

Core Tip: It is often challenging to make therapeutic decisions for patients with inflammatory bowel disease (IBD), given the uncertainty of therapeutic options and diverse patient values. Shared decision-making (SDM) is a process to formulate treatment with patients, trying to clarify and take account of the preferences of patients, increasing their compliance and satisfaction. We summarize current evidence and illustrate the necessity of applying SDM in IBD management.